{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:05:49Z","timestamp":1784894749847,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:00:00Z","timestamp":1744502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.urolonc.2025.04.003","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T07:21:09Z","timestamp":1747293669000},"page":"485-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating the role of adjuvant therapy in improving outcomes for patients with lymph node-positive penile cancer following surgical management"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3473-4446","authenticated-orcid":false,"given":"Radion","family":"Garaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Mirvald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Surcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Muneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Niyazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hathal","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elgin","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olesya","family":"Vakhrusheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Tsaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.04.003_bib0001","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.currproblcancer.2015.03.010","article-title":"Epidemiology of penile cancer","volume":"39","author":"Christodoulidou","year":"2015","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0002","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant Paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0003","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrurol.2017.47","article-title":"Contemporary management of patients with penile cancer and lymph node metastasis","volume":"14","author":"Leone","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0004","doi-asserted-by":"crossref","first-page":"543.e1","DOI":"10.1016\/j.urolonc.2017.04.009","article-title":"Subclassification of pN3 staging systems for penile cancer: proposal for modification of the current TNM classification","volume":"35","author":"Li","year":"2017","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0005","unstructured":"https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/penile.pdf n.d. [accessed 29 December 2024]."},{"key":"10.1016\/j.urolonc.2025.04.003_bib0006","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eururo.2023.04.018","article-title":"Management of lymph node\u2013positive penile cancer: a systematic review","volume":"85","author":"Sachdeva","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0007","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1590\/s1677-5538.ibju.2020.0959","article-title":"Prognostic predictors of lymph node metastasis in penile cancer: a systematic review","volume":"47","author":"Zekan","year":"2021","journal-title":"Int Braz j Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/iju.iju_453_21","article-title":"Pelvic lymph node dissection alone versus adjuvant radiotherapy in node positive penile cancer: a systematic review","volume":"38","author":"Naushad","year":"2022","journal-title":"Indian J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0009","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eururo.2018.04.003","article-title":"Risks and benefits of adjuvant radiotherapy after inguinal lymphadenectomy in node-positive Penile Cancer: a systematic review by the European Association of Urology Penile Cancer Guidelines Panel","volume":"74","author":"Robinson","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0010","doi-asserted-by":"crossref","first-page":"200.e11","DOI":"10.1016\/j.urolonc.2022.02.014","article-title":"Effectiveness and safety of adjuvant chemotherapy compared to neoadjuvant chemotherapy in patients with penile cancer and positive lymph nodes regarding overall survival and free disease survival: a systematic review and meta-analysis","volume":"40","author":"Paz Rojas","year":"2022","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221127254","article-title":"An update on treatment of penile cancer","volume":"14","author":"Chadha","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0012","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.mayocp.2020.06.031","article-title":"Management of advanced penile cancer","volume":"96","author":"Chahoud","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102087","article-title":"Current management and future perspectives of penile cancer: an updated review","volume":"90","author":"Peyraud","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0014","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0b013e3181b12f99","article-title":"Radiation therapy compared with pelvic node resection for node-positive vulvar cancer","volume":"114","author":"Kunos","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0015","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.eururo.2023.02.027","article-title":"European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 update","volume":"83","author":"Brouwer","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1200\/OP.23.00585","article-title":"Penile cancer: EAU-ASCO Collaborative guidelines update Q and A","volume":"20","author":"Brouwer","year":"2024","journal-title":"JCO Oncol Pr"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0017","doi-asserted-by":"crossref","first-page":"605.e17","DOI":"10.1016\/j.urolonc.2017.06.001","article-title":"Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study","volume":"35","author":"Tang","year":"2017","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0018","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.euf.2018.10.007","article-title":"Primary penile cancer: the role of adjuvant radiation therapy in the management of extranodal extension in lymph nodes","volume":"5","author":"Johnstone","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0019","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.juro.2010.10.059","article-title":"Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management","volume":"185","author":"Graafland","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijrobp.2013.08.013","article-title":"Stage presentation, care patterns, and treatment outcomes for squamous cell carcinoma of the penis","volume":"88","author":"Burt","year":"2014","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0021","first-page":"92.e11","article-title":"Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database","volume":"36","author":"Winters","year":"2018"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0022","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2013.07.088","article-title":"Contemporary management of regional nodes in penile cancer\u2014Improvement of survival?","volume":"191","author":"Djajadiningrat","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0023","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/j.prro.2022.11.001","article-title":"Optimizing target volume for adjuvant radiation therapy in penile cancer","volume":"13","author":"Khurud","year":"2023","journal-title":"Pr Radiat Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0024","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.euo.2020.10.011","article-title":"Association between human papillomavirus infection and outcome of perioperative nodal radiotherapy for penile carcinoma","volume":"4","author":"Bandini","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0025","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2020.38.15_suppl.5088","article-title":"Impact of human papillomavirus (HPV) infection on the outcome of perioperative treatments for penile squamous-cell carcinoma (PSCC)","volume":"38","author":"Giannatempo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0026","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.rpor.2019.09.006","article-title":"Intrinsic radiosensitivity, genomic-based radiation dose and patterns of failure of penile cancer in response to adjuvant radiation therapy","volume":"24","author":"Yuan","year":"2019","journal-title":"Rep Pr Oncol Radiother"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0027","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.juro.2011.03.117","article-title":"Radiotherapy for node positive penile cancer: experience of The Leeds Teaching Hospitals","volume":"186","author":"Franks","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0028","doi-asserted-by":"crossref","DOI":"10.1177\/1756287219828972","article-title":"Opportunities for use of radiation therapy in penile cancer based on patterns of care in the United States from 2007 to 2013","volume":"11","author":"Shen","year":"2019","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0029","doi-asserted-by":"crossref","first-page":"531.e7","DOI":"10.1016\/j.urolonc.2019.04.003","article-title":"Nomogram-based prediction of overall survival after regional lymph node dissection and the role of perioperative chemotherapy in penile squamous cell carcinoma: a retrospective multicenter study","volume":"37","author":"Necchi","year":"2019","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0030","doi-asserted-by":"crossref","first-page":"641.e9","DOI":"10.1016\/j.urolonc.2020.03.026","article-title":"Adjuvant radiation compares favorably to chemotherapy in patients with carcinoma penis and nodal positivity restricted to groin","volume":"38","author":"Jaipuria","year":"2020","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0031","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/bju.15309","article-title":"Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis","volume":"128","author":"Ager","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0032","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00345-003-0383-7","article-title":"Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan","volume":"22","author":"Chen","year":"2004","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0033","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clon.2021.10.005","article-title":"Impact of adjuvant treatment in pN3 penile cancer","volume":"34","author":"Khurud","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0034","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-021-00246-5","article-title":"Penile cancer","volume":"7","author":"Thomas","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1590\/S1677-5538.IBJU.2014.0304","article-title":"Feasibility, complications and oncologic results of a limited inguinal lymph node dissection in the management of penile cancer","volume":"41","author":"Tsaur","year":"2015","journal-title":"Int Braz j Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103481","article-title":"Penile cancer: ESMO\u2013EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"9","author":"Muneer","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0037","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.clgc.2017.02.002","article-title":"Clinical outcomes of perioperative chemotherapy in patients with locally advanced penile squamous-cell carcinoma: results of a multicenter analysis","volume":"15","author":"Necchi","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0038","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clgc.2015.07.009","article-title":"A combination of cisplatin and 5-fluorouracil with a taxane in patients who underwent lymph node dissection for nodal metastases from squamous cell carcinoma of the penis: treatment outcome and survival analyses in neoadjuvant and adjuvant settings","volume":"14","author":"Nicolai","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0039","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1200\/jco.2014.32.4_suppl.377","article-title":"Survival analyses of adjuvant or neoadjuvant combination of a taxane plus cisplatin and 5-fluorouracil (T-PF) in patients with bulky nodal metastases from squamous cell carcinoma of the penis (PSCC): results of a single high-volume center","volume":"32","author":"Giannatempo","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0040","doi-asserted-by":"crossref","first-page":"496.e17","DOI":"10.1016\/j.urolonc.2015.05.008","article-title":"Adjuvant chemotherapy is associated with improved overall survival in pelvic node\u2013positive penile cancer after lymph node dissection: a multi-institutional study","volume":"33","author":"Sharma","year":"2015","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0041","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0974-7796.102659","article-title":"Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer","volume":"4","author":"Noronha","year":"2012","journal-title":"Urol Ann"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0042","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00428-014-1713-4","article-title":"Human papilloma virus status of penile squamous cell carcinoma is associated with differences in tumour-infiltrating T lymphocytes","volume":"466","author":"Lohneis","year":"2015","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0043","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.clgc.2016.03.005","article-title":"Prognostic factors of adjuvant taxane, cisplatin, and 5-fluorouracil chemotherapy for patients with penile squamous cell carcinoma after regional lymphadenectomy","volume":"14","author":"Necchi","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0044","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.3346\/jkms.2018.33.e233","article-title":"Prognostic factors of penile cancer and the efficacy of adjuvant treatment after penectomy: results from a multi-institution study","volume":"33","author":"Kim","year":"2018","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1097\/01.JU.0000556432.48421.1e","article-title":"MP49-09 Adjuvant chemotherapy in the treatment of lymph node positive squamous cell carcinoma of the penis: analysis of the national Cancer data base","volume":"201","author":"Raup","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0046","doi-asserted-by":"crossref","DOI":"10.23736\/S0393-2249.19.03387-3","article-title":"Is there any benefit in adding postoperative adjuvant concurrent radiotherapy and chemotherapy for penile cancer with regional lymph node metastasis?","volume":"72","author":"Choo","year":"2020","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0047","doi-asserted-by":"crossref","first-page":"653","DOI":"10.6004\/jnccn.2023.0030","article-title":"Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Benson","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0048","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1002\/cncr.25091","article-title":"Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients","volume":"116","author":"Johnson","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0049","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00345-020-03179-y","article-title":"Radiotherapy plus chemotherapy versus chemotherapy alone in penile cancer patients with extracapsular nodal extension after inguinal lymph node surgery: a multi-institutional study","volume":"39","author":"Li","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/21681805.2020.1776767","article-title":"DaPeCa-4: outcome in penile cancer patients with N3 disease due to extra nodal extension treated with surgery and chemo-irradiation","volume":"54","author":"Maibom","year":"2020","journal-title":"Scand J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0051","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00432-016-2292-3","article-title":"Bilateral pelvic lymph node dissection for Chinese patients with penile cancer: a multicenter collaboration study","volume":"143","author":"Li","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0052","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0053","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.21037\/tau-20-1044","article-title":"Adding radiotherapy based on chemotherapy can improve cancer-specific survival in N3 penile cancer: a SEER-based study","volume":"9","author":"Chen","year":"2020","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0054","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00345-018-2280-0","article-title":"The relationship between HPV status and chemoradiotherapy in the locoregional control of penile cancer","volume":"36","author":"Yuan","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0055","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/1055-9965.EPI-18-0322","article-title":"Prognostic significance of HPV and p16 status in men diagnosed with penile cancer: a systematic review and meta-analysis","volume":"27","author":"Sand","year":"2018","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0056","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.euf.2022.04.012","article-title":"Establishment and characterization of advanced penile cancer patient-derived tumor xenografts: paving the way for personalized treatments","volume":"8","author":"Elst","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0057","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eururo.2024.03.038","article-title":"Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of Human papillomavirus status, and provides clues for treatment personalization","volume":"86","author":"Elst","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0058","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3390\/cancers16112086","article-title":"Therapeutic targets in advanced penile cancer: from bench to bedside","volume":"16","author":"Pagliaro","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0059","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","article-title":"Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches","volume":"27","author":"Udager","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41585-020-0359-z","article-title":"Understanding genomics and the immune environment of penile cancer to improve therapy","volume":"17","author":"Aydin","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0061","article-title":"Advances in molecular basis of response to immunotherapy for penile cancer: better screening of responders","volume":"14","author":"Xu","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0062","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.bjc.6603910","article-title":"Targeting HER proteins in cancer therapy and the role of the non-target HER3","volume":"97","author":"Hsieh","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0063","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3390\/cancers13102323","article-title":"Assessment of PI3K\/mTOR\/AKT pathway elements to serve as biomarkers and therapeutic targets in penile cancer","volume":"13","author":"Thomas","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0064","doi-asserted-by":"crossref","first-page":"848","DOI":"10.21037\/tau.2017.03.92","article-title":"Beyond chemotherapy for advanced disease\u2014the role of EGFR and PD-1 inhibitors","volume":"6","author":"Gu","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/bju.14013","article-title":"First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study","volume":"121","author":"Necchi","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107481","article-title":"Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients","volume":"94","author":"Aydin","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0067","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00345-008-0309-5","article-title":"Radiation therapy in the management of the primary penile tumor: an update","volume":"27","author":"Crook","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0068","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bju.13686","article-title":"Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma","volume":"119","author":"Reddy","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0069","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.juro.2014.12.019","article-title":"Prophylactic pelvic lymph node dissection in patients with penile cancer","volume":"193","author":"Djajadiningrat","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bju.14883","article-title":"Identifying an optimal lymph node yield for penile squamous cell carcinoma: prognostic impact of surgical dissection","volume":"125","author":"Chipollini","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0071","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/JU.0000000000001790","article-title":"Patterns of recurrence following inguinal lymph node dissection for penile cancer: optimizing surveillance strategies","volume":"206","author":"Chakiryan","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0072","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamaoncol.2017.5608","article-title":"Treatment trends and outcomes for patients with lymph node\u2013positive cancer of the penis","volume":"4","author":"Joshi","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0073","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.juro.2014.02.2563","article-title":"Salvage surgical resection for isolated locally recurrent inguinal lymph node metastasis of penile cancer: international study collaboration","volume":"192","author":"Baumgarten","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0074","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00345-019-03052-7","article-title":"Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey","volume":"38","author":"Distler","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0075","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/bju.15177","article-title":"A risk calculator predicting recurrence in lymph node metastatic penile cancer","volume":"126","author":"Bandini","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0076","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.euf.2019.05.010","article-title":"The International Penile advanced Cancer Trial (InPACT): rationale and current status","volume":"5","author":"Canter","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2025.04.003_bib0077","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.21037\/tau-20-945","article-title":"Systemic treatment of penile squamous cell carcinoma\u2014hurdles and hopes of preclinical models and clinical regimens: a narrative review","volume":"10","author":"Thomas","year":"2021","journal-title":"Transl Androl Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925001309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925001309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T11:36:10Z","timestamp":1754912170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925001309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1078143925001309"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.04.003","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the role of adjuvant therapy in improving outcomes for patients with lymph node-positive penile cancer following surgical management","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}